Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,628 | 235 | 99.7% |
| Education | $11.71 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $771.58 | 46 | $0 (2024) |
| Novo Nordisk Inc | $689.21 | 53 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $460.23 | 28 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $285.78 | 19 | $0 (2023) |
| Lilly USA, LLC | $275.89 | 20 | $0 (2024) |
| Amgen Inc. | $274.93 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $184.64 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $135.82 | 9 | $0 (2024) |
| PFIZER INC. | $97.60 | 6 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $92.69 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,097 | 68 | ABBVIE INC. ($358.40) |
| 2023 | $976.68 | 62 | ABBVIE INC. ($269.31) |
| 2022 | $984.85 | 66 | Novo Nordisk Inc ($260.02) |
| 2021 | $421.45 | 27 | Novo Nordisk Inc ($147.61) |
| 2020 | $160.05 | 13 | Lilly USA, LLC ($36.67) |
All Payment Transactions
236 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.04 | General |
| Category: Cardiovascular | ||||||
| 10/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $58.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Bone Health | ||||||
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.98 | General |
| 08/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.45 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 273 | 382 | $121,204 | $20,824 |
| 2020 | 3 | 252 | 289 | $71,786 | $10,836 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 133 | 195 | $76,050 | $13,130 | 17.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 116 | 162 | $44,504 | $7,543 | 17.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 24 | 25 | $650.00 | $149.96 | 23.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 109 | 129 | $37,612 | $5,576 | 14.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 83 | 99 | $21,718 | $3,579 | 16.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 33 | 34 | $9,914 | $1,170 | 11.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 11 | $2,112 | $403.06 | 19.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 16 | 16 | $429.00 | $108.16 | 25.2% |
About Dr. Thomas Hunt, MD
Dr. Thomas Hunt, MD is a Emergency Medicine healthcare provider based in Eau Claire, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013003060.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Hunt, MD has received a total of $3,640 in payments from pharmaceutical and medical device companies, with $1,097 received in 2024. These payments were reported across 236 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,628).
As a Medicare-enrolled provider, Hunt has provided services to 525 Medicare beneficiaries, totaling 671 services with total Medicare billing of $31,660. Data is available for 2 years (2020–2021), covering 8 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Eau Claire, WI
- Active Since 10/05/2006
- Last Updated 03/11/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1013003060
Products in Payments
- TRADJENTA (Drug) $424.53
- QULIPTA (Drug) $394.39
- Rybelsus (Drug) $382.27
- ELIQUIS (Drug) $234.78
- EVENITY (Biological) $191.41
- FARXIGA (Drug) $177.11
- Ozempic (Drug) $140.28
- MOUNJARO (Drug) $138.67
- XARELTO (Drug) $135.82
- RYBELSUS (Drug) $131.60
- UBRELVY (Drug) $127.04
- VRAYLAR (Drug) $113.23
- TRULICITY (Drug) $98.58
- BREZTRI (Drug) $97.10
- VOQUEZNA (Drug) $92.69
- LINZESS (Drug) $87.74
- Otezla (Drug) $71.26
- GLASSIA (Biological) $68.83
- Veozah (Drug) $51.19
- Cologuard Collection Kit (Device) $44.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Eau Claire
Robert Tillotson, Do, DO
Emergency Medicine — Payments: $3,510
Brian Pauley, Md, MD
Emergency Medicine — Payments: $1,327
Matthew Olmstead, D.o, D.O
Emergency Medicine — Payments: $721.10
Dr. Nathaniel Leu, Md, MD
Emergency Medicine — Payments: $226.23
Christian Peterson, Md, MD
Emergency Medicine — Payments: $164.35
William Haselow, M.d, M.D
Emergency Medicine — Payments: $119.86